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Balkan endemic nephropathy (BEN) is a familial chronic tubulointerstitial diseasewith insidious onset and slowprogression leading
to terminal renal failure.The results of molecular biological investigations propose that BEN is a multifactorial disease with genetic
predisposition to environmental risk agents. Exome sequencing of 22 000 genes with Illumina Nextera Exome Enrichment Kit was
performed on 22 DNA samples (11 Bulgarian patients and 11 Serbian patients). Software analysis was performed via NextGene,
Provean, and PolyPhen. The frequency of all annotated genetic variants with deleterious/damaging effect was compared with
those of European populations. Then we focused on nonannotated variants (with no data available about them and not found
in healthy Bulgarian controls). There is no statistically significant difference between annotated variants in BEN patients and
European populations. From nonannotated variants withmore than 40% frequency in both patients’ groups, we nominated 3 genes
with possible deleterious/damaging variants—CELA1, HSPG2, and KCNK5. Mutant genes (CELA1, HSPG2, and KCNK5) in BEN
patients encode proteins involved in basement membrane/extracellular matrix and vascular tone, tightly connected to process of
angiogenesis. We suggest that an abnormal process of angiogenesis plays a key role in the molecular pathogenesis of BEN.
1. Introduction
Balkan endemic nephropathy (BEN) is a familial chronic
tubulointerstitial disease with insidious onset and slow pro-
gression to terminal renal failure. It was first described in
Serbia and in Bulgaria. The disease affects people living
in the alluvial plains along the tributaries of the Danube
River in Serbia, Bosnia, Croatia, Bulgaria, and Rumania [1].
Investigations were directed to the epidemiology, etiology,
morphology, and treatment of BEN. Results of these studies
were reviewed elsewhere [2, 3]. BEN has an onset of between
the 40s and 60s, with a long preclinical period. The disease
affects both genders with slight female predominance and
often leads to terminal kidney failure. About 30–40% of
the affected individuals develop uroepithelial tumours of the
upper urinary tract [4].These are mostly papillar carcinomas
and are the most common causes of death in BEN patients.
Different chemical elements, organic and nonorganic
compounds, viruses, and microorganisms are implicated in
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BEN development. Heavy metals such as Mg, Mo, Cd, Pb As,
and Se can be important for the development of the disease,
but there is no clear evidence of their direct toxic effect on
the development of the disease. Pathomorphologically BEN
has similarities with Chinese herbal nephropathy, which is
probably caused by the toxic effect of aristolochic acid, but
there is no evidence supporting this theory for BEN. Other
possible agents involved in the etiology of BENare ochratoxin
A and some viruses such as picornavirus, polyomavirus, her-
pes simplex 1 and 2, adenovirus, hepatitis B, cytomegalovirus,
and Epstein-Barr virus [5, 6]. For now there is no unchal-
lenged evidence supporting a viral etiopathogenesis of
BEN.
BEN is a multifactorial disease with genetic predisposi-
tion to environmental risk agents. Familial manifestation of
BEN implies a polygenic genetic predisposition [7, 8].
Previous studies have suggested genes located in chro-
mosome band 3q25-3q26, genes for xenobiotic metabolizing
enzymes, tumour-suppressor genes, and protooncogenes.
The incidence of rapid debrisoquine metabolizers is higher
in BEN patients than in healthy controls [9]. CYP2D6
polymorphic variants predisposing to toxic effect of various
chemical agents are suspected in BEN pathogenesis. LCAT-
deficient individuals have evidence of renaltubular injury
and this defect can be involved in BEN [10]. Cytogenetic
research on lymphocyte cultures from BEN patients showed
that in vitro higher folic acid inducedchromosomal fragility
and more frequent spontaneous chromosomal aberrations.
Some of the unstable regions contain oncogenes—1p36-C-
SRC, 3p25-RAF1, 3q27-FIM3, 6q23-MYB, 1p13-NRAS, and
6p11-KRAS1P [11, 12].
Other studies show that environmental factors are very
important and can influence genome function without
changing the DNA sequence itself.The concept of epigenetics
was suggested. The major epigenetic modifications include
DNA methylation, histone modifications, and miRNA inter-
ference [13]. Epigenetic changes over time display familial
clustering [14] and could be implicated in transmitting a
“predisposition” over generations. Epigenetic modifications
being heritable and adaptable at the same time may prove
to make a significant contribution to BEN development
and may be the link between the effect of environmental
factors and genetic composition in BEN progression. In a
previous study we have investigated the methylation sta-
tus across the whole genome in different patient groups,
based on gender and endemic region, in comparison to
healthy controls from nonendemic regions. Differentially
methylated regions (DMRs) were determined in BEN patient
and controls and the commonly presented DMRs were
determined to be the most promising methylation alter-
ations in BEN. SEC61G, IL17RA, and HDAC11 proved to
be differently methylated throughout all patient-control
pairs [15].
In the present studywe aimed to perform exome sequenc-
ing of 22 000 genes with the Illumina Nextera Exome Enrich-
ment Kit using NGS technology in order to find specific
mutations for BEN.
2. Materials and Methods
Twenty-two BEN patients were selected for NGS exome
analysis. Informed consent was received from all participants
enrolled in the study. We obtained peripheral blood samples
from2 series of patients—11 Bulgarian and 11 Serbian. Clinical
assessment was performed according to unified criteria and
was applied to all sample cohorts. Genealogical analysis was
performed to exclude relatives among all study subjects.
Bulgarian samples were collected by preliminary clinical
screening in Vratza endemic regions in Bulgaria in 2003
[16]. All subjects were born of Bulgarian ancestry, born
and living in the endemic region. DNA was extracted by
standard phenol-chloroform extraction procedure and stored
at −80∘C. All samples were checked for DNA consistency by
1% gel electrophoresis.
Serbian samples were collected from Serbian endemic
regions. DNAwas extracted byDNAextraction kit and stored
at −80∘C. All samples were checked for DNA consistency by
1% gel electrophoresis.
The study was approved by the Serbian Ethics Committee
of the University of Nis, School of Medicine, Nis, Serbia, and
the Bulgarian Commission of Medical Ethics at the National
Center of Hygiene, Medical ecology and Nutrition, Sofia,
Bulgaria.
2.1. Library Preparation and Enrichment. Theworkflow in the
Nextera Enrichment Sample Preparation Guide (Revision B)
by Illumina was followed to prepare the libraries for whole-
exome sequencing. A Nextera Exome Enrichment Kit was
used. The 22 libraries were distributed in 10 enrichment
reactions (“pools”)—in 6 of them DNA from 3 libraries was
mixed together, while the other 4 contained DNA from only
one. The latter were prepared in order to obtain higher mean
coverage for these samples. A different DNA quantity (500 ÷
1000 ng) was added to form each pool depending on the
quantity of the least concentrated sample in the reaction.
2.2. Library Quantification. After completing the enrichment
procedure, DNA concentration of the 10 sequencing-ready
pools was measured using a KAPA Library Quantification
Kit.The reactions were run in triplicate on an Illumina qPCR
Eco system.The Eco Study software was used to calculate the
concentrations of the dilutions and then of the stocks.
2.3. Denaturation and Dilution. Pools 5–10 were denatured
and diluted according to the Illumina guidelines in Preparing
DNA Libraries for Sequencing on the MiSeq (Illumina, San
Diego, USA). Due to lower concentrations Pools 1–4 were
prepared for sequencing following the corresponding chapter
in the TruSeq Custom Amplicon Library Preparation Guide,
which uses heat denaturation instead of denaturation with
0.1 N NaOH.
2.4. Sequencing. The pools were sequenced on an Illumina
MiSeq System using the MiSeq Reagent Kit v2 and a 500-
cycle 14-tile flow cell. Only Pool 9 was sequenced using a 300-
cycle MiSeq Reagent Micro Kit v2 and a micro 4-tile flow
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Table 1: Nonannotated variants with frequency of more than 40% in BEN patients, discovered in our study.
Number of patients Gene Chr Position Exon Mutation Aminoacid change Protein
11 HSPG2 1 22186113 43 c.5239A>C p.Thr1747Pro Heparan sulfate proteoglycan 2
10 CELA1 12 51740414 2 c.9 10delC p.Leu4Phefs Chymotrypsin-like elastase family, member 1
9 KCNK5 6 39162513 4 c.1397A>C p.Thr108Pro Potassium channel, subfamily K, member 5
cell. We experimented loading the flow cell at different pool
concentrations (10 ÷ 30 pM) to establish what the optimal
range is for the most efficient cluster density and hence yield.
2.5. Analysis. Analysis of the sequencing data was performed
using the Softgenetics NextGene Software (version 2.3.3).
The variants found were further analyzed by mutation
prediction software Provean and PolyPhen-2 to filter the
mutations, which are predicted to be deleterious/damaging.
We searched for repeated mutations that are unique or that
have significantly higher frequencies in BEN patients as
compared to individuals from European populations. We
focused on nonannotated variants, predicted as possibly dele-
terious/damaging by software analysis.We selectedmutations
based on the following criteria: (i) no data about variants; (ii)
no incidence in healthy Bulgarian controls and in European
populations; (iii) similar incidence in both Bulgarian and
Serbian patients’ groups; (iv) mutation frequency of more
than 40% in BEN patients.
3. Results
Twenty-two Bulgarian and Serbian BEN patients were ana-
lyzed by NGS exome sequencing for 22 000 genes. Using the
Softgenetics NextGene Software (version 2.3.3) the sequenc-
ing data were analyzed. Mutation prediction was performed
by software Provean and PolyPhen-2.
We discovered in total 3666 missense variants with
possible deleterious/damaging effect in our patients’ groups.
Among them, 1849 (50%) were not annotated.
In total, 980 nonsense and frameshift variants were
detected in our study. Among them, 541 (55%) variants have
not been annotated in human genome data base of genetic
variations or no information about their frequency was
available.
Among the annotated variants with possible deleteri-
ous/damaging effect we did not find statistically signif-
icant difference in the frequency between BEN patients
and European populations. From nonannotated variants, we
selected the variants with frequency of more than 40% in
BEN patients—HSPG2, CELA1, and KCNK5 (Table 1). These
mutations, alone or in combination, occur in 77% of BEN
patients.
The probable contribution of each of the nominated genes
to the pathogenesis of BEN (according to their mutation
frequency) is represented in Figure 1. The frequencies of
each of the nominated mutant genes for Bulgarian and
Serbian BEN patients are given in Figure 2. All selected
variants occur with similar frequency in the Bulgarian and
37%
30%
33%
HSPG2
KCNK5
CELA1
Figure 1: Nominated candidate genes, associated with BEN.
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Figure 2: Frequency of nominated mutant genes in Bulgarian and
Serbian BEN patients.
Serbian groups of BEN patients. The nominated variants
are classified according to their function—genes involved in
the constitution of basement membrane/extracellular matrix
(ECM) (HSPG2 and CELA1) and gene for renal potassium
transport and membrane potential (KCNK5).
Figure 3 represents the distribution of the three mutant
genes in all BEN patients. KCNK5 variant c.1397A>C occurs
only in combination with one or two of the other variants
(HSPG2 c.5239A>C and CELA1 c.9 10delC), while CELA1
variant is present as a single aberration in 6 out of 10 positive
cases. In 5 of BEN patients none of these variants were
found. This is probably due to the presence of other rare
mutations, which did not pass the threshold criteria in our
study (presented in more than 40% of the patients).
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KCNK5
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Figure 3: Combination of the three mutant genes found in all BEN patients. Pb: Bulgarian patients; Ps: Serbian patients.
4. Discussion
Balkan endemic nephropathy has been traditionally
described as an end-stage kidney disease, characterized by
bilaterally and symmetrically contracted kidneys of a very
small size and reduced weight, coinciding with multiple
upper urinary tract tumors in 8–48% of cases [17]. Basic
histomorphological changes include tubular atrophy and
interstitial fibrosis with sclerosed glomeruli usually of
collapsing obsolescence and sclerotic changes in blood
vessels. The hypothesis for BEN multifactorial pathogenesis
[8] proposes that inherited genetic defects predispose the
kidney to damage after exposure to different agents—toxic,
immune, or infective. The familial clustering of the disease
has prompted genetic investigations [12, 18, 19].
This is the first analysis by NGS sequencing in BEN
patients aimed at discovering mutations associated with
the disease. Despite intensive molecular studies in BEN,
the etiopathogenesis of the disease is still not elucidated
and there is no biomarker for disease predisposition. Most
of the molecular studies so far have focused on single
genes/polymorphisms and very limited information has
been provided. Because gene-by-gene analysis by Sanger
sequencing is too laborious and expensive, genetic testing
has been the exception until recently. Now, next-generation
sequencing (NGS) allows for simultaneous and efficient
analysis of all known genes for a given trait. Here we
applied exome sequencing (comprised of 22 000 genes) in
22 BEN patients in order to detect the most prominent
genetic variants with highly probable pathological effect.
Recently Poon et al. have applied whole-genome and exome
sequencing for analysis of Aristolochic acid- (AA-) associ-
ated upper urinary tract urothelial cell carcinoma (UTUC)
[20]. AA is a carcinogen that can cause nephrotoxicity
as well. Authors observed a high frequency of somatic
mutations in chromatin modifiers, particularly KDM6A, in
AA-UTUC, demonstrated the sufficiency of AA to induce
renal dysplasia in mice, and reproduced the AA mutational
signature in experimentally treated human renal tubular
cells. Our study was looking for germ-line mutations pre-
disposing to another specific nephropathy-Balkan endemic
nephropathy.
Three genes (HSPG2, CELA1, and KCNK5) were nomi-
nated as related to the pathogenesis of BEN based on their
mutation frequency, their similar incidence in both Bulgarian
and Serbian patients’ groups, lack of information about the
established variants in European population, and noninci-
dence in healthy Bulgarians. Analysis of their function sheds
light on the possible pathophysiology in BEN, which we
discuss here.
The first two genes HSPG2 and CELA1 are evidently
involved in the process of angiogenesis. The gene KCNK5
encodes a protein for potassium channel, which could also
be involved in vascular disease and complications.
The number of patients requiring renal replacement
therapy due to end-stage renal disease (ESRD) is increasing
worldwide [21]. The prevalence of chronic kidney disease
(CKD) and the importance of CKD as a risk factor in
development of ESRD have been confirmed. In recent
years, the involvement of angiogenesis-related factors in the
progression of CKD has been studied, and the potential
therapeutic effects on CKD of modulating these factors have
been identified [22]. A number of angiogenic growth factors
are involved in the development of the kidney and in the
maintenance of glomerular structures and the glomerular
filtration barrier function in adults.
Our study revealed significant candidate gene—HSPG2,
which encodes perlecan protein, a major component of
basementmembranes, where it is involved in the stabilization
of other molecules important for glomerular permeability to
macromolecules and for cell adhesion [23, 24]. It binds to and
crosslinks many extracellular matrix components and cell-
surfacemolecules [25–29]. It has been shown that this protein
interacts with laminin, prolargin, collagen type IV, tenascin-
C, FGFBP1, FBLN2, FGF7, transthyretin, and so forth, and
plays essential roles in multiple biological activities. Cukura-
novic et al. have intensively studied the pathological changes
in the kidneys of BEN patients and presented evidence that
renal vascular changes occur early in Balkan nephropathy
[30]. They detected by IHC a marked overexpression of
laminin in renal interstitial capillaries.The pattern of laminin
staining in glomeruli corresponded to focal and segmental
glomerular sclerosis present in the advanced stages of Balkan
nephropathy. Later stages were characterized by an intensive
expression of laminin in atrophic tubules, much more in
proximal than in distal ones. The coexpression of vimentin
and cytokeratin in proximal tubular cells was also demon-
strated. The changes described, particularly those taking
place at the level of interstitium, bear the key responsibility
for BEN progression.
CELA1, the second nominated gene, is also involved in
the process of angiogenesis [31]. The gene encodes elastase-
1, which degrades elastin in the vascular matrix. Tumor
angiogenesis, chicken angiogenesis, and mesenteric angio-
genesis data suggest that elastin and elastin degradation
products play a key role in vascular morphogenesis. CELA1
was expressed in vascular cells in the embryonic lung and in
a fetal mesenchymal cell line with angiogenic properties [32].
Degraded elastin causes deposition of hydroxyapatite-like
mineral and osteogenic transformation of vascular smooth
muscle cells (as they lose the specific 𝛼-SMA), resulting in
vascular calcification [33]. In contrast, collagen-1 levels in
areas of calcification are increasing [34]. Changes in both 𝛼-
SMA and elastin inversely correlate with the hemodynamic
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parameters such as pulse wave velocity (PWV) and lead to
media remodeling. This was associated with the increased
arterial stiffness observed in CKD rats with vascular cal-
cification. Dysregulation of normal anticalcification factors
and elastin degradation represent a pattern of vascular injury
existing in patients with end-stage renal diseases [35].
The third gene nominated in our study was the potassium
channel gene KCNK5. Potassium channels in the kidney
play an essential role in controlling and maintaining plasma
potassium levels in the normal range, as well as exerting
very different functions such as cell volume control, mem-
brane potential stabilization and excitability, or regulation of
hormone or ion secretion [36–39]. In addition, potassium
ion (K+) channel activity is a major regulator of vascular
muscle cellmembrane potential and is therefore an important
determinant of vascular tone. There is growing evidence
that the function of several types of vascular K+ channels
is altered during major cardiovascular diseases, such as
chronic hypertension, diabetes, and atherosclerosis [40].
Defects in potassium channels cause abnormal vasodila-
tion responses reflecting a gradual deterioration of vascular
mechanisms during the progression of diabetic nephropathy
[41]. Enhanced dilator responses and basal activation of K+
channels may occur in the renal circulation early during
diabetes. An increased K+ channel activity may therefore
reflect a very high metabolic state of vascular smooth muscle
cells [42].
5. Conclusion Hypothesis for the Pathogenic
Mechanism in BEN
The molecular mechanisms leading to interstitial fibrosis
and chronic kidney disease are complex and are probably
related to the primary processes leading to renal injury.
As blood vessels nourish all the tissues and organs in the
body, abnormal formation and remodeling of blood vessels
probably contribute to the pathogenesis of renal fibrosis.
Neoangiogenesis is a complex process of recruitment, migra-
tion, proliferation, and apoptosis of stem/progenitor cells,
endothelial cells, vascular smooth muscle cells, and other
mural cells. The extracellular matrix plays important roles in
vessel development via providing a supportivematrix scaffold
and growth factors for cells. Close interactions between
vascular cells and their ECM is crucial in blood vessel for-
mation and remodeling. Our results suggest three new genes
for predisposition to BEN pathology, related to angiogenic
alterations.Wehypothesize thatmutations inHSPG2,CELA1,
andKCNK5 participate in extracellular matrixmodifications,
arterial media remodeling, and regulation of vascular tone,
all these events leading to interstitial vessel remodeling,
connected to renal interstitial fibrosis in BEN (Figure 4).
Further elucidation of molecular pathogenesis of kidney
fibrosis could lead to the development of a new target therapy
of BEN by targeting specific angiogenic factors. Our results
provide a basis for further investigations of the role of
the nominated genes in BEN kidney pathology, including
screening for variants in the nominated genes in a larger
HSPG2
CELA1
KCNK5
Extracellular
matrix
modifications
Arterial media
remodeling
Regulation of
vascular tone
Vessel remodeling,
interstitial microvascular network,
glomerular sclerosis
Renal interstitial fibrosis—BEN
Figure 4: Proposed model for molecular pathogenesis of BEN
kidney pathology.
cohort of patients. Herein we suggest a possible mechanism
between the three candidate genes and BEN.
The main pathological characteristic of BEN kidney
is interstitial fibrosis. Abnormal angiogenesis and vascular
remodeling probably contribute to pathogenesis of renal
fibrosis. Interactions between endothelial cells, vascular
smoothmuscle cells and progenitor cells with an extracellular
matrix (ECM) play an important role in these processes.
Scattered glomeruli showing an obvious segmental or global
thickening of the capillary walls with a double outline of the
glomerular basement membrane were found in early BEN
patients.
Interstitial sclerosis could result from the overproduction
of extracellular matrix by injured proximal tubular epithe-
lium and interstitial capillary endothelial cells—this could be
the pathogenic role of mutated HSPG2 gene. The increase
of the cortical interstitial volume results in resistance of
the postglomerular capillary network with impairment of
the glomerular flow [43]. This impairment leads to chronic
rise in hydrostatic pressure. The increase of the cortical
interstitium additionally leads to an increase in the length
of diffusion between the tubules and the intertubular and
peritubular capillaries.This increase in the length of diffusion
subsequently results in the atrophy of the tubules, reduction
of reabsorbtion, and therefore impairment of the effective
filtration pressure. The haemodynamic changes inversely
correlate with 𝛼-SMA and elastin in vessels and here could
be the additional pathogenic role of mutated CELA1 gene.
ThemutatedKCNK5 gene is probably a factor stimulating the
haemodynamics-driven vascular remodeling.
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